bioRxiv · 10.1101/197616
Native and engineered clifednamide biosynthesis in multiple Streptomyces spp.
Abstract
Polycyclic tetramate macrolactam (PTM) natural products are produced by actinomycetes and other bacteria. PTMs are often bioactive, and the simplicity of their biosynthetic clusters make them attractive for bioengineering. Clifednamide-type PTMs from Streptomyces sp. JV178 contain a distinctive ketone group, suggesting the existence of a novel PTM oxidizing enzyme. Here, we report the new cytochrome P450 enzyme (CftA) is required for clifednamide production. Genome mining was used to identify several new clifednamide producers, some having improved clifednamide yields. Using a parallel synthetic biology approach, CftA isozymes were used to engineer the ikarugamycin pathway of Streptomyces sp. NRRL F-2890 to yield clifednamides. Further, we observed that strong CftA expression leads to the production of a new PTM, clifednamide C. We demonstrate the utility of both genome mining and synthetic biology to rapidly increase clifednamide production and identify a PTM tailoring enzyme for rational molecule design.
Source connections
Explore related subjects
Keep this discovery
Qi, Y., Ding, E., Blodgett, J.. 2017-10-03. Native and engineered clifednamide biosynthesis in multiple Streptomyces spp.. https://doi.org/10.1101/197616
Cite the original work for its findings. Save a collection to share your selection of sources.